Actuarial experts with Milliman, a health benefits consulting firm, recently authored a study examining the complex financial effects of the Inflation Reduction Act’s (IRA) changes to Medicare’s prescription drug benefit. (The study was commissioned by the Pharmaceutical Research and…
[ad_2]
Source link
